Miosite por Corpos de Inclusão Familiar (MCIF)

Atualização

Autores

  • Marco Orsini Physical therapist, Associate Professor of Neurologic Rehabilitation, Escola Superior de Ensino Helena Antipoff (ESEHA), Voluntary Assistant of the Department of Neurology, Universidade Federal Fluminense – UFF, Niterói-RJ, Brazil.
  • Mariana Pimentel Mello Physical Therapist and Student of the Program of Scientific Initiation, Neurology Department, UFF, Niterói-RJ, Brazil.
  • Marcos RG de Freitas Neurologist, Head of Staff, Department of Neurology, UFF, Niterói-RJ, Brazil.
  • Osvaldo JM Nascimento Neurologist, UFF, Niterói-RJ, Brazil.

DOI:

https://doi.org/10.34024/rnc.2009.v17.8579

Palavras-chave:

Miosite, Corpos de Inclusão, Doenças Neuromusculares

Resumo

Miosite por corpos de inclusão familiar é uma doença extremamente rara, caracterizada por início tardio, seletivo e com precoce envolvimento dos músculos quadríceps, flexores dos dedos e do antebraço, e ligeiro aumento nos níveis séricos de creatina cinase (CK). Histologicamente as fibras musculares apresentam vacúolos marginados e infiltrados inflamatórios. A combinação de achados clínicos, imunopatológicos, histológicos e imunogênicos indicam que esses pacientes apresentam uma doença de características similares a miosite por corpos de inclusão esporádica.

Métricas

Carregando Métricas ...

Downloads

Não há dados estatísticos.

Referências

Sivakumar K, Semino-Mora C, Dalakas MC. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis: Studies in three families. Brain 1997;120:653-61.

Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.

Ranque-Francois B, Maisonobe T, Dion E, Piette JC, Chauveheid MP, Amoura Z, et al. Familial inflammatory inclusion body myositis. Ann Rheum Dis 2005;64:634-37.

Tateyama M, Saito N, Fujihara K, Shyga Y, Takeda A, Narikawa K, et al. Familial Inclusion Body Myositis: A Report on Two Japanese Sisters. Int Med 2003;42:1035-8.

Askanas V, Engel WK. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Curr Opin Rheumatol 1995;7:486-96.

Hilton-Jones D. Diagnosis and treatment of inflammatory muscle diseases. J Neurol Neurosurg Psychiatr 2003; 74(Suppl II):ii25-31.

Mizusawa H. The familial occurrence may give a clue to the pathogenesis of inclusion body myositis. Int Med 2003;42:928-9.

Naumann M, Reichmann H, Goebel HH, Moll C, Toyka KV. Glucocorticoid-sensitive hereditary inclusion body myositis. J Neurol 1996;243:126-30.

Amato AA, Shebert RT. Inclusion body myositis in twins. Neurology 1998;51:598-600.

Hengstman GJ, van Engelen BG, ter Laak HJ, Gabreels-Festen AA. Familial inclusion body myositis with histologically confirmed sensorimotor axonal neuropathy. J Neurol 2000;247:882-4.

Askanas V, Engel WK. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: Disease of oxidative stress and aging? Arch Neurol 1998;55:915-20.

Tawil R, Griggs RC. Inclusion body myositis. Curr Opin in Rheumatol 2002;14:653-7.

Dalakas MC. Sporadic inclusion body myositis - diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006;2:437-47.

Askanas VA, Engel WK. New advances in inclusion-body myositis. Curr Opin Rheumatol 1993;5:732-41.

Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001;29:83-7.

Argov Z, Eisenberg I, Mitrani-Rosenbaum S. Genetics of inclusion body myopathies. Curr Opin Rheumatol 1998;10:543-7.

Askanas V, Engel WK. Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. J Neuropathol Exp Neurol 2001;60:1-14.

Fyhr IM, Moslemi AR, Mosavi AA, Lindberg C, Tarkowski A, Oldfors A. Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis. J Neuroimmunol 1997;9:185-9.

Koffman BM, Sivakumar K, Simonis T, Stroncek D, Dalakas MC. HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 1998;84:139-42.

Garlepp MJ, Laing B, Zilko PJ, Oilier W, Mastaglia FL. HLA associations with inclusion body myositis. Clin Exp Immunol 1994;98:40-5.

Sivakumar K, Dalakas MC. The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews. Neurology 1996;47:977-84.

Downloads

Publicado

2009-06-30

Como Citar

Orsini, M., Mello, M. P., Freitas, M. R. de, & Nascimento, O. J. (2009). Miosite por Corpos de Inclusão Familiar (MCIF): Atualização. Revista Neurociências, 17(2), 193–195. https://doi.org/10.34024/rnc.2009.v17.8579

Edição

Seção

Atualização

Artigos Semelhantes

1 2 3 4 5 6 7 8 9 10 > >> 

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.

Artigos mais lidos pelo mesmo(s) autor(es)

1 2 3 4 5 > >>